Literature DB >> 8063032

Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.

R Pezzilli1, P Billi, L Gullo, E Beltrandi, M Maldini, R Mancini, L Incorvaia, M Miglioli.   

Abstract

When activated, lymphocytes secrete glycoproteins related to particular surface proteins, including soluble forms of the interleukin-2 receptor (sIL-2R) and of the surface proteins CD4 (sCD4) and CD8 (sCD8). We evaluated the release of these glycoproteins in order to assess the activation of the cellular immune system during the course of acute pancreatitis. Thirty-five patients with acute pancreatitis (22 M, 13 F, mean age 64 years, range 16-97) were studied. The diagnosis was based on typical abdominal pain associated with a twofold increase of serum lipase as well as morphological abnormalities compatible with acute pancreatitis seen at computed tomography and/or ultrasonography. The pancreatitis was of biliary origin in 22 patients, due to alcohol abuse in 8, due to pancreas divisum in 1, due to type IV hyperlipoproteinemia in 1 and of unknown origin in 3. Based on clinical outcome, 22 patients had mild pancreatitis, whereas 13 had severe disease. In all patients serum sIL-2R, sCD4 and sCD8 were determined on admission and daily for the following 5 days using enzyme immunoassay (EIA) techniques. Serum concentrations of sIL-2R and sCD8 were significantly higher in acute pancreatitis patients relative to healthy controls during the entire observation period, whereas sCD4 levels were significantly lower in acute pancreatitis patients than in the control group from the 2nd to the 6th day of observation. Serum sIL-2R concentrations were significantly higher in patients with severe pancreatitis than in those with the mild form of the disease, whereas no differences in serum concentrations of sCD8 and sCD4 were found between patients with mild pancreatitis and those with severe disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063032     DOI: 10.1159/000201159

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  17 in total

1.  Assessment of severity of acute pancreatitis: a comparison between old and most recent modalities used to evaluate this perennial problem.

Authors:  Raffaele Pezzilli; Francesco Mancini
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis.

Authors:  T Salomone; P Boni; C Serra; A M Morselli-Labate; A L Di Gioia; M Romboli; A Guariento
Journal:  Int J Pancreatol       Date:  1996-12

Review 3.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 4.  Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma.

Authors:  Lei Zheng; Jing Xue; Elizabeth M Jaffee; Aida Habtezion
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

Review 5.  Immune cells and immune-based therapy in pancreatitis.

Authors:  Jing Xue; Vishal Sharma; Aida Habtezion
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

6.  Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis.

Authors:  R Pezzilli; G V Melzi d'Eril; A M Morselli-Labate; G Merlini; B Barakat; T Bosoni
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 7.  Essential role of monocytes and macrophages in the progression of acute pancreatitis.

Authors:  Pratima Shrivastava; Madhav Bhatia
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

Review 8.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

9.  Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications.

Authors:  J Mayer; B Rau; F Gansauge; H G Beger
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

10.  Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein.

Authors:  R Pezzilli; P Billi; R Miniero; M Fiocchi; O Cappelletti; A M Morselli-Labate; B Barakat; G Sprovieri; M Miglioli
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.